Probable autoimmune lymphoproliferative syndrome with monogenic lupus due to KRAS mutation - A rare encounter

Main Article Content

Amiya Nayak
Pratyusha Gudapati
Swapnil Tripathi
Jasmita Dass
Mukul Aggarwal
Pradeep Kumar

Keywords

autoimmune lymphoprolifearive syndrome, monogenic lupus, KRAS, RAS associated leukoproliferative disorder

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a disease characterized by dysfunction of the T lymphocyte  apoptotic pathways, mostly due to dysfunctional FAS mediated signaling. However few cases can also occur independent of FAS pathway alteration. ALPS is characterized by various immuno-hematological manifestations. Monogenic lupus is an evolving entity, which describes the etiologic role of single gene modulation in systemic lupus erythematosus. In this manuscript, we describe a case of probable ALPS with monogenic lupus caused by a novel mutation in the KRAS gene.

Downloads

Download data is not yet available.


Abstract 130
PDF Downloads 128
HTML Downloads 11

References

1. Speckmann C, Borkhardt A, Gaspar HB et al (2017) Genetic disorders of immune regulation. In: Primary immunodefciency diseases. Springer-Verlag Berlin Heidelberg 2017:295–338

2. Oliveira, Joao B et al. “Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.” Blood vol. 116,14 (2010): e35-40. doi:10.1182/blood-2010-04-280347

3. Neven, Quentin et al. “Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).” Journal of clinical immunology vol. 41,1 (2021): 51-58. doi:10.1007/s10875-020-00883-7

4. Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio, Yoshihito Kasahara, Kenichi Koike, Seiji Kojima, Akira Takao, Shuki Mizutani; Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation. Blood 2011; 117 (10): 2887–2890

5. Alperin JM, Ortiz-Fernández L and Sawalha AH (2018) Monogenic Lupus: A Developing Paradigm of Disease. Front. Immunol. 9:2496. doi: 10.3389/fimmu.2018.02496

6. Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis. (2011) 70:151–6. doi: 10.1136/ard.2010.141697

7. .E. Niemela, L. Lu, T.A. Fleisher, J. Davis, I. Caminha, M. Natter, L.A. Beer, K.C. Dowdell, S. Pittaluga, M. Raffeld, V.K. Rao, J.B. Oliveira, Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis, Blood 117 (2011) 2883–2886.

8. Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, Del Bel KL, TarailoGraovac M, van Karnebeek C, et al. The importance of considering monogenic causes of autoimmunity: a somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus. Clin Immunol. 2017;175:143–6

9. Huang, Lamei et al. “KRAS mutation: from undruggable to druggable in cancer.” Signal transduction and targeted therapy vol. 6,1 386. 15 Nov. 2021, doi:10.1038/s41392-021-00780-4